insights_auto
Why is EYPT down ४.३९%?
Dive Deeperchevron_right
EYPT:NASDAQ
EyePoint Inc
US$ ३.२७
arrow_downward
-४.३९%(-०.१५) 1D
US$ ३.३३
arrow_upward
+१.८३% (+०.०६०)bedtimeAfter hours
Closed: सेप्टेम्बर ३०, १६:००:०१ GMT-४ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EYPT...
Open
US$ ३.४२
High
US$ ३.४६
Low
US$ ३.२५
Mkt. cap
२८.१९ करोड
Avg. vol.
४५.७५ लाख
Volume
३४.३५ लाख
52-wk high
US$ १९.०१
52-wk low
US$ ३.२५
EPS
-US$ ३.७४
Beta
१.६३
Shares outstanding
८.६२ करोड
No. of employees
२१४
Open
US$ ३.४२
High
US$ ३.४६
Low
US$ ३.२५
Mkt. cap
२८.१९ करोड
Avg. vol.
४५.७५ लाख
Volume
३४.३५ लाख
52-wk high
US$ १९.०१
52-wk low
US$ ३.२५
EPS
-US$ ३.७४
Beta
१.६३
Shares outstanding
८.६२ करोड
No. of employees
२१४
Profile
EyePoint Pharmaceuticals Inc. is a Watertown, Massachusetts company specialising in the application of microelectromechanical systems and nanotechnology to drug delivery.
pSivida obtained porous silicon technology from the British government Defence Evaluation and Research Agency. QinetiQ continues to be a strategic partner.
In June 2004, pSivida acquired full ownership of pSiMedica. In April 2018, pSivida purchased eye products firm Icon Bioscience. Afterwards, it rebranded to its current name of EyepOint Pharmaceuticals, Inc. Wikipedia
About EyePoint Inc
CEO-
Employees२१४
Founded२०००
HeadquartersWatertown, म्यासेचुसेट्स, संयुक्त राज्य अमेरिका
Sector-
Websiteeyepoint.bio